Quest Diagnostics (NYSE: DGX) has acquired the toxicology and clinical laboratory business of medical center operator Concentra, a subsidiary of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE